HaemAnalytica Next Generation Platelet Analysis

Precision

Health

Clarity

Precision assays to determine the Health impacts of drug efficacy and off-target effects, providing the Clarity needed to treat patients and derisk drug development.

Transforming cardiovascular disease treatment.

Transforming drug discovery.

Next generation platelet analysis

Innovations in multi-parameter cell based assays, following 20 years of R&D, to develop fundamental new ways to measure platelet function in clinical trials, diagnostics and research.

Revolutionising blood analysis

Our technology uses multiparameter platelet function analysis to transform:

Diagnostics

Clinical trials

Drug discovery

Pre-clinical biomedical research

HaemAnalytica at ISTH 2026, Paris

13 Jul 2026 13:45 - 15:00

Hear from Maria Diaz Alonso & Joanne Dunster on TRIPLEcheck and PLANA, chaired by Prof. Jon Gibbins, CSO and Co-founder of HaemAnalytica.

Girls In Stem International Day of Women and Girls in Science: Inspiring the next generation

7 Jul 2026

For International Day of Women and Girls in Science, we joined the ARC Mindset event in Manchester, inspiring girls aged 14-16 into STEM. Our COO, Gemma Little, spent the day discussing platelets and blood clotting with students — with a little help from our resident "Platelet Pal".

HaemAnalytica at BioNow Precision Medicine

13 Jul 2026 13:45 - 15:00

Bill and Gemma exhibited at Precision Medicine, enjoying sessions on personalised treatment approaches. TRIPLEcheck was designed to identify individuals at risk of heart attacks and strokes, and it was great to hear other exciting developments.

See all news and events

Our technologies in a nutshell

HaemAnalytica’s next generation technologies set a new standard for stratification of patients and the assessment of on- and off-target drug effects on bleeding and thrombosis.

Multi-parameter assays and AI-based phenotyping, enabling insightful platelet analysis to de-risk clinical trials and enhance drug development.

HaemAnalytica at ISTH 2026

Monday 13th July, 13:45 – 15:00
OC44 Revolutionising platelet and thrombus formation assays

Talks are being given by Maria Diaz Alonso and Joanne Dunster, members of the academic team that have developed TRIPLEcheck and PLANA.
The session is being chaired by Prof. Jon Gibbins, CSO and Co-founder of HaemAnalytica

To arrange a meeting with Jon at ISTH, please email
info@haemanalytica.com

Home | Privacy policy | Manage cookies

Registered in England, company number 15921838

Web design by Tribal Systems

Send us a message

Sorry, this form requires you to accept Analytics and Functional cookies before it can load. Click here to allow these types of cookie.

Precision assays to determine the Health impacts of drug efficacy and off-target effects, providing the Clarity needed to treat patients and derisk drug development.

Transforming cardiovascular disease treatment.

Transforming drug discovery.

Next generation platelet analysis

Revolutionising blood analysis

Diagnostics

Clinical trials

Drug discovery

Pre-clinical biomedical research

Latest news and events

HaemAnalytica at ISTH 2026, Paris

13 Jul 2026 13:45 - 15:00

Girls In Stem International Day of Women and Girls in Science: Inspiring the next generation

7 Jul 2026

HaemAnalytica at BioNow Precision Medicine

13 Jul 2026 13:45 - 15:00

Our technologies in a nutshell

HaemAnalytica’s next generation technologies set a new standard for stratification of patients and the assessment of on- and off-target drug effects on bleeding and thrombosis.

HaemAnalytica at ISTH 2026

Monday 13th July, 13:45 – 15:00 OC44 Revolutionising platelet and thrombus formation assays

Send us a message

Monday 13th July, 13:45 – 15:00
OC44 Revolutionising platelet and thrombus formation assays